BioSpace News Archive

Agenus Inc. announced today that its Biotech Electronic Security Token will be launched on Feb. 19. 2019.

International Society for Applied Biological Sciences (ISABS), Mayo Clinic and St. Catherine Hospital are organizing “11th ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine” (http://www.isabs.net) in Split, Croatia, June 17th - June 22th, 2019.

The opioid crisis is devastating individuals, families and communities across the country. Without increased access to effective, evidence-based treatment options, people with substance use disorders will continue to be at risk for overdose.

Merion, Inc. (OTCQB: EWLU), based in Los Angeles, focused on high-tech small molecules +cell carrier nutrient products, today announced that David Li, Financial Adviser, will present live at VirtualInvestorConferences.com on February 20th.

Vivacelle Bio, Inc. today announces that the US. Food and Drug Administration (FDA) has granted it an Investigational New Drug (IND) clearance to proceed with its phase IIa clinical trial of the safety and efficacy of VBI-1.

Increased Investment and a Key Hire - Biopharma and Healthcare Market

Cambrooke Therapeutics, a member of The Ajinomoto Group, and Trovita Health Science, a specialty medical nutrition company, announce a joint marketing and development partnership for ENU® Nutrition meal replacement shakes.

Experts from the ProfNet network who are available to discuss timely issues in your coverage area.

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at Leerink Partners 8th Annual Global Healthcare Conference on Thursday, February 28, 2019, at 10:00 a.m. ET.

Polarean Imaging plc (AIM: POLX), the medical imaging technology company, with a proprietary drug device combination product for the magnetic resonance imaging (MRI) market, announces that it has entered into a contract for the procurement of its latest polarizer system by the University of British Columbia www.ubc.ca (“UBC”) following the conclusion of UBC’s procurement process.